|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 2768524 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12780408.6 |
| Date of filing the European patent application | 2012-10-17 | |
| (97) | Date of publication of the European application | 2014-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-04 |
| (46) | Date of publication of the claims translation | 2022-07-25 |
| (86) | Number | PCT/DK2012/050386 |
| Date | 2012-10-17 |
| (87) | Number | WO 2013/056716 |
| Date | 2013-04-25 |
| (30) | Number | Date | Country code |
| 201170574 P | 2011-10-17 | DK |
| (72) |
ANDERSEN, Mads Hald , DK
|
| (73) |
IO Biotech ApS ,
Ole Maaløes Vej 3, 2200 Copenhagen N,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PD-L1 grindžiama imunoterapija |
| PD-L1 BASED IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 14 | 289.00 EUR |
| 2026-10-17 |